{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2984, 
        2990
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3130, 
        3136
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3152, 
        3166
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2991, 
        3000
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3137, 
        3146
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2776, 
        2799
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3241, 
        3261
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2878, 
        2905
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2918, 
        2922
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3074, 
        3079
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3209, 
        3211
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3229, 
        3231
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        696, 
        725
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1302, 
        1337
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3178, 
        3204
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2975, 
        2983
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3121, 
        3129
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2910, 
        2916
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3066, 
        3072
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3212, 
        3218
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3232, 
        3238
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2907, 
        2909
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3063, 
        3065
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3206, 
        3208
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3226, 
        3228
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160504154612|3E18C547BF5DED0B84DE9E9D925F997EA5ACD161|ORU^R01|99999999999999999999|P|2.5|\nPID|1||99999999^^^^CMR^HOSPITAL 9&9999&MOH~99999999^^^^^HOSPITAL 9&9999&MOH~99999999^^^^MRN^HOSPITAL 9&9999&MOH~9999999999&TN&ON^^^^JHN||XXXXXXX^XXXXXX XXXXXXX||99999999|F||F|999 XXXXX XXXXX XX^^XXXXXX^XX^X9X9X9^999||9999999999^TN^OHIN|||D||7848013434^TN^OHIN||||||||||||N|\nOBR|1||SP1617220|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160427090500|||83384^XXXXXX^XXXXX-XXXXXX^^^^XX||||20160427133305|LT Breast Stereo&RT Breast|999999^XXXXXX^XXXXX-XXXXXX^^^^XX||||N|20082009|20160504154613|||F|||||||99999^XXX^XXXXXX^^^^XX, XXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1. The specimen is received in a container labelled with the patient's name, who has the initials \"SLT\" and \"Lt breast stereo\". The specimen consists of multiple irregularly shaped fragments of yellow to tan fibroadipose tissue mixed with hemorrhagic debris, measuring in aggregate 3.0 x 1.5 x 0.5 cm.\nIn toto: 1A-1D\n2. The specimen is received in a container labelled with the patient's name, who has the initials \"SLT\" and the specimen site \"Rt breast\".\nNumber of pieces: 7\nDimension: 0.3 x 0.1-1.4 x 0.1 cm\nOther:  Nil\n2A-2B - in toto\nSC   2016-04-28   TOH Civic Campus\n\n\nPath report.microscopic observation\n\n1. The specimen is quite fragmented. Small foci of invasive carcinoma are seen with tissue fragments in blocks 1A, 1C and 1D. The largest focus is 1.9 mm (block 1C-level 6). The invasive carcinoma is estimated to be of low Nottingham histologic grade (tubules 2/3, nuclei 2/3, mitoses 1/3, overall score 5/9). In addition, there are abundant detached fragments of malignant epithelium and detached calcifications. These cannot be assessed as to whether they represent invasive or in situ carcinoma. No intact ductal carcinoma in situ (DCIS) is identified. There are ducts showing at least atypical ductal hyperplasia (ADH) with associated calcifications.\nRepresentative slides from block 1C were also seen by Dr. S. Pyatibrat, who agrees with the diagnosis of invasive carcinoma.\n2. Sections demonstrate invasive ductal carcinoma involving all submitted breast tissue cores. A component of the invasive carcinoma is of no special type and a component shows micropapillary morphology. In this limited sample, the carcinoma shows focal tubule formation, a range of nuclear grade from moderate to high within the micropapillary areas, and scattered mitotic activity. The carcinoma is of estimated intermediate Nottingham histologic grade. No definite in situ component is identified. Definitive tumour grading and subtyping will be performed on the final excision specimen. Focal calcifications are present within adjacent benign glands.\n\n\nPath report.relevant Hx\n\n(L) breast superior microcalcifications BIRADS 4A\nMass RT breast BIRADS 4B\n\n\nPath report.final diagnosis\n\n1. Breast, left, stereotactic vacuum-assisted core needle biopsy:\n- INVASIVE DUCTAL CARCINOMA, 1.9 mm largest contiguous span (see microscopic description)\n2. Breast, right, ultrasound-guided core needle biopsy:\n- INVASIVE DUCTAL CARCINOMA WITH MICROPAPILLARY FEATURES\n\n\nPath report.site of origin\n\n1. LT Breast Stereo\n2. RT Breast\n\n\nPath report.comments\n\nER, PR and HER2 testing will be performed on the excision specimen. If required on this biopsy sample, please forward a request with the appropriate clinical information to the anatomical pathology laboratory at The HOSPITAL 12 (FAX: 613-737-8853). Blocks 1C and 2A would be appropriate for biomarker testing.\n\n\n"
}